Production (Stage)
Vigil Neuroscience, Inc.
VIGL
$7.89
$0.010.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -2.97% | -1.99% | 1.70% | 9.93% | 19.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.49% | 0.92% | 5.42% | 13.73% | 20.42% |
| Operating Income | -2.49% | -0.92% | -5.42% | -13.73% | -20.42% |
| Income Before Tax | -4.77% | -1.96% | -4.66% | -10.42% | -13.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.77% | -1.96% | -4.66% | -10.42% | -13.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.77% | -1.96% | -4.66% | -10.42% | -13.77% |
| EBIT | -2.49% | -0.92% | -5.42% | -13.73% | -20.42% |
| EBITDA | -2.49% | -0.86% | -5.26% | -13.47% | -20.02% |
| EPS Basic | 3.05% | 3.01% | -1.27% | -4.02% | 0.08% |
| Normalized Basic EPS | 3.04% | 3.01% | -1.27% | -4.03% | 0.08% |
| EPS Diluted | 3.05% | 3.01% | -1.27% | -4.02% | 0.08% |
| Normalized Diluted EPS | 3.04% | 3.01% | -1.27% | -4.03% | 0.08% |
| Average Basic Shares Outstanding | 8.14% | 5.05% | 3.46% | 6.10% | 12.77% |
| Average Diluted Shares Outstanding | 8.14% | 5.05% | 3.46% | 6.10% | 12.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |